UMIN ID: UMIN000054103
Registered date:11/04/2024
COVI-19 breakthrough infection in hemodialysis patients during an Omicron epidemic
Basic Information
| Recruitment status | Complete: follow-up complete |
|---|---|
| Health condition(s) or Problem(s) studied | COVID-19 breakthrough infection |
| Date of first enrollment | 2022/01/04 |
| Target sample size | 200 |
| Countries of recruitment | Japan |
| Study type | Observational |
| Intervention(s) |
Outcome(s)
| Primary Outcome | Factors that differentiate breakthrough-infected and non-Infected individuals |
|---|---|
| Secondary Outcome | Prognosis of breakthrough-infected and non-iInfected patients |
Key inclusion & exclusion criteria
| Age minimum | 18years-old |
|---|---|
| Age maximum | 100years-old |
| Gender | Male and Female |
| Include criteria | |
| Exclude criteria | None |
Related Information
| Primary Sponsor | Fujita Memorial Hospital |
|---|---|
| Secondary Sponsor | |
| Source(s) of Monetary Support | Fujita Memorial Hospital |
| Secondary ID(s) |
Contact
| public contact | |
| Name | Ryoichi Miyazaki |
| Address | 4-15-7, Houei, Fukui City Japan 910-0004 |
| Telephone | 0776211277 |
| ryoichi@mitene.or.jp | |
| Affiliation | Fujita Memorial Hospital Internal Medicine |
| scientific contact | |
| Name | Ryoichi Miyazaki |
| Address | 4-15-7, Houei, Fukui City Japan |
| Telephone | 0776211277 |
| ryoichi@mitene.or.jp | |
| Affiliation | Fujita Memorial Hospital Internal Medicine |